Genmab | GEN - Trade Debtors


Genmab reported DKK1.17B in Trade Debtors for its fiscal quarter ending in December of 2025.





Trade Debtors Change Date
Agios Pharmaceuticals USD 16.13M 5.56M Mar/2026
Almirall EUR 196.15M 20.22M Jun/2026
Amarin USD 126.83M 477K Dec/2025
Amgen USD 10.23B 1.09B Jun/2026
argenx SE USD 2.01B 352.94M Jun/2026
AstraZeneca USD 18.86B 972M Jun/2026
Bayer EUR 18.55B 4.36B Mar/2026
BioMarin Pharmaceutical USD 903.91M 4.3M Mar/2026
Demant DKK 5.5B 262M Dec/2025
Exelixis USD 328.95M 42.03M Mar/2026
Fresenius Medical Care EUR 3.72B 58.09M Mar/2026
Genmab DKK 1.17B 119M Dec/2025
GlaxoSmithKline GBP 8.07B 137M Jun/2026
GN Store Nord DKK 2.44B 2.86B Mar/2026
GRIFOLS EUR 1.19B 231M Jun/2026
Hikma Pharmaceutical USD 1.08B 27M Dec/2025
Insmed USD 215.32M 36.77M Jun/2026
Lakefront Biotherapeutics EUR 54.03M 145.72M Mar/2026
Lonza CHF 1.78B 55M Dec/2025
Merck EUR 4.81B 373M Mar/2026
Novartis USD 9.85B 252M Jun/2026
Regeneron Pharmaceuticals USD 6.57B 834.4M Jun/2026
Roche Holding CHF 13.34B 1.44B Jun/2026
Sanofi EUR 492M 10M Jun/2026
UCB EUR 1.97B 54M Dec/2025